IP Library Granted Patent US 9,271,929
Granted Patent B2
US 9,271,929 · App. 13/130,892 · Granted Mar 1, 2016

Block copolymers and uses thereof

Inventors: James Brandon Dixon (Marietta, GA); Jeffrey A. Hubbell (Preverenges, CH); Conlin P. O'Neil (Chavannes-renens, CH); Melody Swartz (Preverenges, CH); Diana Velluto (Lausanne, CH)
Assignee: École Polytechnique Fédérale de Lausanne (EPFL)
A61K9/1075A61K9/1273A61K9/5146C08G65/329C08G65/3344C08G75/08C08G83/008C08L71/02A61K48/0041C08L81/02C08L2203/02C08L2205/05Y10S977/773Y10S977/906Y10S977/916
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,271,929
App. No.
13/130,892
Granted
Mar 1, 2016
Kind
B2
Abstract

An encoding/decoding apparatus and method using a low-density parity-check code (LDPC code) is disclosed. Basic column group information, serving as a set of information regarding positions of rows with weight 1, is extracted from a reference column in each column group of a predetermined parity-check matrix. Column group information transforms the positions of rows with weight 1 into positions whose lengths are within a required parity length. A parity-check matrix is generated according to the generated column group information. Data is encoded or decoded based on the generated parity-check matrix.

Claims (11)

1. A micelle comprising both poly(ethylene glycol)-poly(propylene sulfide) (PEG-PPS) and poly(ethylene glycol)-poly(propylene sulfide)-poly(ethyleneimine) (PEG-PPS-PEI) block copolymers.

2. The micelle of claim 1 , wherein said micelle is between 20 and 50 nm in diameter.

3. The micelle of claim 1 , wherein the PEG-PPS-PEI copolymer comprises a bond between the PPS and PEI block that is labile in an endosome.

4. The micelle of claim 3 , wherein said labile bond is selected from the group consisting of vinyl ether, orthoester, acyl hydrazone, a disulfide bond, or a —N—PO 3 — group.

5. The micelle of claim 1 , wherein the PEG-PPS-PEI block further comprising a nucleic acid complexed to PEI.

6. The micelle of claim 5 , wherein said nucleic acid is selected from the group consisting of a single stranded oligonucleotide, an antisense oligonucleotide a small interfering RNA (siRNA), an aptamer, or plasmid DNA.

7. A pharmaceutical composition comprising the block copolymer of claim 1 and further comprising a pharmaceutically acceptable diluent.

8. A dry formulation comprising the micelles of claim 1 , wherein said formulation comprises less than 5% water by weight.

9. The formulation of claim 8 , wherein said formulation comprises less than 2% water by weight.

10. A method of transfecting a cell with a nucleic acid comprising contacting said cell with the micelle of claim 5 .

11. A method of transfecting a cell with a nucleic acid comprising contacting said cell with the micelle of claim 6 .

Continuity (2)
Provisional Application 61117892 · Nov 25, 2008
Related Publication 20110223217A1 · Sep 15, 2011